Vol. 13 Nbr. 2, June 2008
- New antiretroviral agents and the complexity of treatment practices: If you don't know what N155H means then you shouldn't be treating HIV-infected patients.
- New drugs.
- Integrase inhibitors: a clinical review of raltegravir and elvitegravir.
- New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
- Trends of prevalence of primary HIV drug resistance in Germany.